DCP Capital to Acquire Vitaco

Paul, Weiss is advising DCP Capital on its acquisition of Australia- and New Zealand-based Vitaco Health Group, a leading maker of sports nutrition products, dietary supplements and health foods, from Shanghai Pharmaceuticals and Primavera Capital. The deal values Vitaco at approximately $450 million. The transaction is expected to close in December 2026 or early 2027, subject to customary closing conditions.

The Paul, Weiss team is led by corporate partner Judie Ng Shortell and includes antitrust partner Chad de Souza and litigation counsel Joshua Thompson.